期刊文献+

长期腹膜透析伴糖尿病及包裹性腹膜硬化一例

A Case of Long-term Peritoneal Dialysis with Diabetes Mellitus and Encapsulated Peritoneal Sclerosis
下载PDF
导出
摘要 目的回顾一例长期腹膜透析(peritoneal dialysis,PD)并同时患有糖尿病及包裹性腹膜硬化(encapsulating peritoneal sclerosis,EPS)的患者临床相关资料,提高对包裹性腹膜硬化的认识,并提出EPS与糖尿病之间可能存在相同作用机制的假设。方法通过对本例报道的临床资料整理及相关文献复习,分析包裹性腹膜硬化病因、临床特征及影像表现。结果维持性腹膜透析患者伴发糖尿病的情况下,小肠壁钙化、外周血管钙化较严重,易出现并发症,且预后不好。结论长期腹膜透析应警惕EPS的发生,EPS早期发现困难,预后差,尤其伴有糖尿病时,患者并发症严重,病死率较高。 Objective To review the clinically relevant data of a patient with long-term peritoneal dialysis(peritoneal dialysis,PD)with diabetes and encapsulating peritoneal sclerosis(encapsulating peritoneal sclerosis,EPS),improve the awareness of parcel peritoneal sclerosis,and propose the hypothesis that the same mechanism of action may exist between EPS and diabetes.Methods We analyze the etiology,clinical features and imaging performance of the clinical data and related literature.Results In maintenance peritoneal dialysis patients with diabetes,small intestinal wall calcification,peripheral vascular calcification,severe complications,and poor prognosis.Conclusion Long-term peritoneal dialysis should be alert to the occurrence of EPS,difficulties in the early detection of EPS,poor prognosis,especially with diabetes,patients with serious complications and high fatality rate.
作者 张红梅 赵云妍 吕爱清 ZHANG Hongmei;ZHAO Yunyan;LV Aiqing(Department of Radiology,Beijing Zhongguancun Hospital,Haidian District,Beijing 100080)
出处 《智慧健康》 2022年第8期77-79,共3页 Smart Healthcare
关键词 腹膜透析 包裹性腹膜硬化 糖尿病 腹膜增厚 钙化 Peritoneal dialysis Encapsulated peritoneal sclerosis Diabetes Peritoneal thickening Calcification
  • 相关文献

参考文献6

二级参考文献45

  • 1涂曦文,彭佑铭,唐东兴,谭太发,李丽文.维持性血液透析患者血管钙化及相关因素分析[J].中国动脉硬化杂志,2015,23(6):613-616. 被引量:25
  • 2Schmidt MI,Duncan BB,Sharrett AR,et al.Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Riskin Communities study):a cohort study.Lancet,1999,353:1649-1652.
  • 3Pradhan AD,Manson JE,Rifai N,et al.C-reactive protein,interleukin 6,and risk of developing type 2 diabetes mellitus.JAMA,2001,286:327-334.
  • 4Freeman DJ,Nor'ie J,Caslake MJ,et al.C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study.Diabetes,2002,51:1596-1600.
  • 5Festa A,D'Agostino R Jr,Tracy RP,et al.Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes:the insulin resistance atherosclerosis study.Diabetes,2002,51:1131-1137.
  • 6Brooks-Worrell BM,Reichow JL,Goel A,et al.Identification of autoantibody-negative autoimmune type 2 diabetic patients.Diabetes Care,2011,34:168-173.
  • 7Tabák AG,Kivimaki M,Brunner EJ,et al.Changes in Creactive protein levels before type 2 diabetes and cardiovascular death:theWhitehall Ⅱ study.Eur J Endocrinol,2010,163:89-95.
  • 8Schroder K,Zhou R,Tschopp J.The NLRP3 inflammasome:a sensor for metabolic danger?.Science,2010,327:296-300.
  • 9Carstensen M,Herder C,Kivimaki M,et al.Accelerated increase in serum interleukin-1 receptor antagonist starts 6 years beforediagnosis of type 2 diabetes:Whitehall Ⅱ prospective cohort study.Diabetes,2010,59:1222-1227.
  • 10Luotola K,Pietil(a) A,Zeller T,et al.Associations between interleukin-1 (IL-1) gene variations or IL-1 receptor antagonist levelsand the development of type 2 diabetes.J Intern Med,2011,269:322-332.

共引文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部